PRKACA has also been studied in the context of cancer, where its aberrant regulation and overexpression have been related to inflammatory activation of Caspase 1, oncogene activation, and elevated PGE2 levels (Almeida et al., 2011). This evidence concerns the gene CASP1 and cancer.